Sanket S. Dhruva

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Sanket Dhruva, Sanket S Dhruva, Sanket Shishir Dhruva
Publication record
235 papers · 3,853 citations · H-index 29

PAPERS

Therapeutic Benefit Ratings for FDA Breakthrough-Designated Devices.
20260 citationsauthor #4
Shared Decision-Making and Patient Decision Aids for Percutaneous Left Atrial Appendage Occlusion
20261 citationsauthor #4
Cardiovascular Statistics in the United States, 2026: JACC Stats.
20263 citationsauthor #2
The Food and Drug Administration's role in supporting therapeutic development to address unmet needs: the National Academies report and beyond
20260 citationsauthor #1
Relationship Between Industry Payments to Physicians and Prescription Patterns for PCSK9is, ARNis and DOACs: A Report from the NCDR PINNACLE Registry.
20250 citationsauthor #9
PO-07-200 POSTCARDS TO IMPROVE REMOTE MONITORING CONNECTIVITY: A RANDOMIZED, CONTROLLED TRIAL
20250 citationsauthor #1
Abstract 4360144: Effectiveness of Elective Endovascular Intervention for Patients with Peripheral Arterial Disease and Intermittent Claudication
20250 citationsauthor #1
Hospital Acquisition Costs for Breakthrough-Designated Devices Awarded Supplemental Medicare Reimbursement
20250 citationsauthor #3
FDA Authorization of Therapeutic Devices Under the Breakthrough Devices Program.
20256 citationsauthor #2
Evaluation of Payer Policies to Reduce Low-Value Medical Device–Based Procedure Use
20250 citationsauthor #1
The Role of Clinicians in Advancing Cardiovascular Device Safety.
20250 citationsauthor #2
Artificial Intelligence to Propel Evidence Generation.
20250 citationsauthor #1
Nonconcurrent Control Use in FDA Approval of High-Risk Medical Devices
20252 citationsauthor #2
OUTCOMES ASSOCIATED WITH A CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICEDERIVED HEART FAILURE RISK SCORE
20250 citationsauthor #6
Expanding Prior Authorization in Traditional Medicare-The WISeR Model.
20252 citationsauthor #2
Research Derived From Medicare’s Coverage With Evidence Development Program
20250 citationsauthor #6
Assessing Medicare's Coverage With Evidence Development Program.
20251 citationsauthor #4
Post Market Data-Real World Safety Evaluation of Pulsed Field Ablation - and Beyond.
20250 citationsauthor #1
Abstract 4122120: Prospective Implementation of a Cardiovascular Implantable Electronic Device Algorithm-Based Management Pathway in Routine Heart Failure Care
20240 citationsauthor #7
Abstract 4115684: Outcomes Associated with Remote Monitoring without In-person Evaluations for Patients with Cardiovascular Implantable Electronic Devices
20240 citationsauthor #7
Physicians' Perspectives On FDA Regulation Of Drugs And Medical Devices: A National Survey.
202418 citationsauthor #1
Prescription Digital Therapeutics: The Authors Reply.
20240 citationsauthor #3
Prices and complications in hospital-based and freestanding surgery centers.
20248 citationsauthor #3
Medical Devices Applying for Outpatient Medicare Supplemental Payments
20241 citationsauthor #5
Representativeness of Studies Required Under Medicare's Coverage With Evidence Development Program.
20241 citationsauthor #2
Implementation of a Cardiovascular Implantable Electronic Device Heart Failure Prediction Tool-Guided Management Pathway: CIED-Guided Heart Failure Management.
20242 citationsauthor #7
INFORMATIONAL LETTERS OR POSTCARDS TO INITIATE REMOTE MONITORING AMONG PERSISTENTLY NON-ADHERENT VETERANS WITH PACEMAKERS AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: A RANDOMIZED, CONTROLLED TRIAL
20240 citationsauthor #5
Industry Payments to Cardiology Fellows and Early-Career Cardiologists.
20241 citationsauthor #1
Medicare Local Coverage Determinations: Evidence Quality Is Stronger For Covered Indications.
20242 citationsauthor #6
Decreasing unnecessary use of continuous cardiac monitoring (telemetry) in hospitalised patients
20240 citationsauthor #4
Intravascular Microaxial Left Ventricular Assist Device Manufacturer Payments to Cardiologists and Use of Devices.
20246 citationsauthor #1
Use of electronic health records to characterize patients with uncontrolled hypertension in two large health system networks
20241 citationsauthor #5
Medicare Coverage and Patient Out-of-Pocket Costs for Cardiovascular-Kidney-Metabolic Medications
20246 citationsauthor #5
Use of Electronic Health Records to Characterize Patients with Uncontrolled Hypertension in Two Large Health System Networks
20240 citationsauthor #5
If We Measure, We Can Improve.
20240 citationsauthor #2
MEDICARE UTILIZATION AND SPENDING ON THE 10 DRUGS SELECTED FOR NEGOTIATION UNDER THE INFLATION REDUCTION ACT
20240 citationsauthor #3
Availability of Unique Device Identifiers for Class I Medical Device Recalls From 2018 to 2022.
20234 citationsauthor #4
Ventricular arrhythmia detection for contemporary Biotronik and Abbott implantable cardioverter defibrillators with markedly prolonged detection in Biotronik devices
20234 citationsauthor #2
Deep Learning of Electrocardiograms in Sinus Rhythm From US Veterans to Predict Atrial Fibrillation.
202344 citationsauthor #3
INFORMATIONAL POSTCARDS IMPROVE ACCESS TO REMOTE MONITORING AMONG VETERANS WITH PACEMAKERS AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: A STEPPED-WEDGE RANDOMIZED CONTROLLED TRIAL
20231 citationsauthor #5
Aligning US Agency Policies for Cardiovascular Devices Through the Breakthrough Devices Program.
202310 citationsauthor #5
Use of Recalled Devices in New Device Authorizations Under the US Food and Drug Administration's 510(k) Pathway and Risk of Subsequent Recalls.
202325 citationsauthor #2
Financial Conflicts of Interest in Public Comments on Medicare National Coverage Determinations of Medical Devices.
20231 citationsauthor #7
Unique Device Identifiers for Medical Devices at 10 Years.
20236 citationsauthor #1
Abstract 13591: Utilization and Spending on Fixed-Dose Combination Treatment for Hypertension in Medicare and Medicaid, 2016-2020
20231 citationsauthor #3
The Need for Randomized Clinical Trials Demonstrating Reduction in All-Cause Mortality With Blood Tests for Cancer Screening.
20234 citationsauthor #1
Identifying treatment heterogeneity in atrial fibrillation using a novel causal machine learning method
20238 citationsauthor #5
Trends in FDA Adverse Events Reporting for Inferior Vena Cava Filters and Estimated Insertions in the US, 2016 to 2020.
20238 citationsauthor #2
Systematic Reprogramming of Implantable Cardioverter Defibrillators to Match the 2019 Consensus Recommendations.
20231 citationsauthor #3
Adding device identifiers to claims forms—a key step to advance medical device safety
20239 citationsauthor #2
A Critical Examination of Independent Medical Review Decision-making for Cardiovascular Procedures Shows Low Rate of Evidence Citation in Reviews
20230 citationsauthor #3
Abstract 15925: Comparative Mortality, Safety, and Cost Among Stroke Patients Who Received Implantable Loop Records Compared to Continuous External Cardiac Monitors
20230 citationsauthor #1
Physician Responses to Apple Watch-Detected Irregular Rhythm Alerts.
20239 citationsauthor #2
Studies Of Prescription Digital Therapeutics Often Lack Rigor And Inclusivity.
202315 citationsauthor #6
MONITORING AND CLINICAL OUTCOMES OF REPROGRAMMABLE IMPLANTABLE LOOP RECORDERS WITH ALGORITHMS TO REDUCE FALSE POSITIVE ALERTS
20230 citationsauthor #4
Characterization of US Food and Drug Administration Class I Recalls from 2018 to 2022 for Moderate- and High-Risk Medical Devices: A Cross-Sectional Study
20238 citationsauthor #4
Assessing the use of observational methods and real-world data to emulate ongoing randomized controlled trials
20237 citationsauthor #4
Safety and Effectiveness of a Catheter With Contact Force and 6-Hole Irrigation for Ablation of Persistent Atrial Fibrillation in Routine Clinical Practice
20225 citationsauthor #1
Emulating the GRADE trial using real world data: retrospective comparative effectiveness study
202221 citationsauthor #4
SAFETY AND EFFECTIVENESS OF THERMOCOOL ST CATHETER FOR ABLATION OF PERSISTENT ATRIAL FIBRILLATION USING REAL-WORLD DATA
20220 citationsauthor #1
SAFETY AND EFFECTIVENESS OF THERMOCOOL STSF CATHETER FOR ABLATION OF ISCHEMIC VENTRICULAR TACHYCARDIA
20220 citationsauthor #1
Cardiovascular Implantable Electronic Device Lead Safety: Harnessing Real-World Remote Monitoring Data for Medical Device Evaluation.
20226 citationsauthor #11
Physician Responses to Apple Watch-Detected Irregular Rhythm Alerts: A Case-Based Survey
20220 citationsauthor #2
Analysis of Patient-Focused Information About Left Atrial Appendage Occlusion on US Hospital Web Pages.
20221 citationsauthor #1
2021 Update on Pediatric Overuse.
20226 citationsauthor #8
Strategies to Manage Drugs and Devices Approved Based on Limited Evidence: Results of a Modified Delphi Panel
20226 citationsauthor #1
Implantable cardioverter-defibrillator placement among patients with left ventricular ejection fraction ≤35 % at least 40 days after acute myocardial infarction
20220 citationsauthor #8
THE HARMS ASSOCIATED WITH INFERIOR VENA CAVA FILTERS
20220 citationsauthor #1
CARDIAC CORONARY TOMOGRAPHY ANGIOGRAPHY (CCTA) USE ACROSS GEOGRAPHIC REGIONS IN THE UNITED STATES AND THE UNITED KINGDOM
20220 citationsauthor #2
Abstract 78: Cardiovascular Implantable Electronic Device Lead Safety: Harnessing Real-world Remote Monitoring Data For Medical Device Evaluation
20220 citationsauthor #11
Abstract 43: A Case-based Survey Of Physician Practice Patterns Following Asymptomatic, Wearable Device-detected Irregular Rhythm
20220 citationsauthor #2
Long-term Outcomes in Use of Opioids, Nonpharmacologic Pain Interventions, and Total Costs of Spinal Cord Stimulators Compared With Conventional Medical Therapy for Chronic Pain.
202242 citationsauthor #1
Characterization of multi-domain postoperative recovery trajectories after cardiac surgery using a digital platform
202210 citationsauthor #2
NATIONAL MEDICARE FORMULARY COVERAGE AND OUT-OF-POCKET COSTS OF QUADRUPLE THERAPY FOR HEART FAILURE WITH REDUCED EJECTION FRACTION
20221 citationsauthor #4
Abstract 13439: Trends in Spending for P2Y12 Inhibitors by Medicare and Medicaid
20220 citationsauthor #3
US Food and Drug Administration-Mandated Postmarketing Studies for High-risk Cardiovascular Devices Approved 2015-2019.
20228 citationsauthor #2
Factors Associated with Remote Monitoring Adherence for Cardiovascular Implantable Electronic Devices.
202217 citationsauthor #7
Assessment of Hypothetical Out-of-Pocket Costs of Guideline-Recommended Medications for the Treatment of Older Adults With Multiple Chronic Conditions, 2009 and 2019.
202229 citationsauthor #3
Medicare's New Device-Coverage Pathway - Breakthrough or Breakdown?
20217 citationsauthor #4
Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock
202194 citationsauthor #1
Stepped‐Wedge Randomized Clinical Trial of Social Marketing Strategies to Improve Adherence to Remote Monitoring Among Veterans with Pacemakers and Implantable Cardioverter‐Defibrillators
20210 citationsauthor #1
Feasibility of Using Real-world Data to Emulate Postapproval Confirmatory Clinical Trials of Therapeutic Agents Granted US Food and Drug Administration Accelerated Approval
202122 citationsauthor #5
Clinical studies sponsored by digital health companies participating in the FDA’s Precertification Pilot Program: A cross-sectional analysis
20213 citationsauthor #2
Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death.
202124 citationsauthor #4
Feasibility of capturing real-world data from health information technology systems at multiple centers to assess cardiac ablation device outcomes: A fit-for-purpose informatics analysis report
202116 citationsauthor #2
QUANTIFYING THE UNDERREPORTING OF DEATH FOR CARDIOVASCULAR DEVICES IN THE FDA MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE (MAUDE) DATABASE
20210 citationsauthor #4
Electrical Abnormalities with St. Jude/Abbott Pacing Leads: A Systematic Review and Meta-analysis.
20214 citationsauthor #5
Changing FDA Approval Standards: Ethical Implications for Patient Consent
202114 citationsauthor #2
Real-world Cardiovascular Outcomes Associated With Degarelix vs Leuprolide for Prostate Cancer Treatment
202134 citationsauthor #4
Assessment of FDA Approval for New High-risk Therapeutic Devices Not Meeting Pivotal Study Primary End Points, 2016-2020.
20215 citationsauthor #2
Trajectories of Pain After Cardiac Surgery: Implications for Measurement, Reporting, and Individualized Treatment
202110 citationsauthor #3
Characteristics, interventions and outcomes of patients with valvular heart disease hospitalised in China: a cross-sectional study
202111 citationsauthor #2
Physical activity, patient-reported symptoms, and clinical events: Insights into postprocedural recovery from personal digital devices
20214 citationsauthor #7
Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions From 2015 to 2020
202110 citationsauthor #2
Author's reply to the Editor - Denominator Neglect in Meta-analysis: Electrical Abnormalities in St. Jude/Abbott Pacing Leads.
20210 citationsauthor #2
Media Portrayals of Extracorporeal Membrane Oxygenation: The Unforeseen Harm of Unfounded Optimism.
20212 citationsauthor #2
B-PO04-048 PATIENT CHARACTERISTICS ASSOCIATED WITH ADHERENCE TO REMOTE MONITORING OF CARDIOVASCULAR IMPLANTABLE ELECTRONIC DEVICES
20210 citationsauthor #7
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009–2018
202019 citationsauthor #3
Physician and Patient Adjustment to Reference Pricing for Drugs
20207 citationsauthor #4
2019 Update on Pediatric Medical Overuse: A Systematic Review.
202020 citationsauthor #7

TIMELINE

2008 136 citations

2009 262 citations

2010 52 citations

2011 132 citations

2012 79 citations

2013 13 citations

2014 18 citations

2015 452 citations

2016 161 citations

2017 344 citations

2018 565 citations

2019 556 citations

2020 459 citations

2021 260 citations

2022 152 citations

2023 165 citations

2024 46 citations

2025 11 citations

2026 4 citations

Sanket S. Dhruva

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT